retatrutide type 2 diabetes phase 2 trial 2024 results Retatrutide, a GIP, GLP-1 and glucagon receptor Lilly's triple agonist, retatrutide, demonstrated
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18





























